CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models

By  

THE PROSTATE, Vol. 75, Iss. 12, 2015-07 ,pp. : 1227-1246

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of Surgical Treatment for Metastatic Vertebra Bone Tumor in Advanced Lung Cancer

By  

Case Reports in Oncology, Vol. 3, Iss. 1, 2010-03 ,pp. : 63-71

Karger

Access to resources Recommend Favorite

Long-Term Disease Stabilization in a Patient with Castration-Resistant Metastatic Prostate Cancer by the Addition of Lenalidomide to Low-Dose Dexamethasone and Celecoxib

By  

Oncology Research and Treatment, Vol. 35, Iss. 5, 2012-04 ,pp. : 279-282

Karger

Access to resources Recommend Favorite

Treatment of metastatic prostate cancer

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 4, 2015-07 ,pp. : 7-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 217-221

Karger

Access to resources Recommend Favorite